Lead sponsor
Novartis Pharmaceuticals
21 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
21
Trials led
1
Ongoing
8,431
Total enrollment
766
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
5
Phase 2/3
2
Phase 3
6
Phase 4
7
Trials by status
Recruiting
1
Completed
16
Terminated
4
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineMMSE 10-24Ph 3Completed1,584
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseAlzheimer's diseasePh 3Completed1,040
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 3Completed859
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular DementiaStudy partner/caregiver requiredPh 3Completed708
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's DiseaseAlzheimer's diseasePh 3Completed501
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseAlzheimer's diseasePh 2Recruiting407
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)Alzheimer's diseasePh 3Completed216
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsAlzheimer's diseasePh 2Completed177
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementiamild-to-moderate ADPh 4Completed121
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.Alzheimer's diseasePh 4Completed100
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)mild-to-moderate ADPh 1Completed58